Janus Henderson Group
AZN icon

Janus Henderson Group’s AstraZeneca AZN Stock Holding History

Janus Henderson Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,619
Closed -$1.86M – 2414
2025
Q1 		$1.86M Buy
+12,619
New +$1.83M ﹤0.01% 1316

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Janus Henderson Group's AZN Position: Q1 2026 in Review

Janus Henderson Group increased its AstraZeneca (AZN) stake by 1,880% in Q1 2026, buying an estimated $2.19B and bringing the position to 11,949,424 shares worth $2.32B. The position accounts for 1.11% of the portfolio, ranked #10.

Janus Henderson Group first reported a position in AZN in Q3 2014 and has held it in 45 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Janus Henderson Group held 11,949,424 shares of AstraZeneca worth $2.32B as of Q1 2026.
  • Janus Henderson Group bought 11,345,846 AstraZeneca shares in Q1 2026, an estimated $2.19B.
  • AstraZeneca made up 1.11% of Janus Henderson Group's portfolio in Q1 2026, its #10 holding.
  • Janus Henderson Group first reported a position in AstraZeneca in Q3 2014 and has held it in 45 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.